## Abstract The presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1βmethy1β4βphenylβ1,2,3,6βtetrahydropyridine. Polymorphisms in the dopamine transporter might influence the susceptibility to such toxins.
Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan
β Scribed by Masataka Nishimura; Ryuji Kaji; Mitsuhiro Ohta; Ikuko Mizuta; Sadako Kuno
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 305 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
We studied a polymorphism in the dopamine transporter (DAT) gene in 236 Japanese patients with Parkinson's disease (PD) and compared the results with 220 controls. The 1215A/G genotype of the DAT gene was significantly different between PD patients and controls, suggesting a possible involvement of DAT in genetic susceptibility to PD.
π SIMILAR VOLUMES
## Abstract Altered levels of the neurotransmitters dopamine and serotonin are observed in both Parkinson's disease (PD) and depression. Therefore, the neurotransmitter transporter genes, __SLC6A3__ (dopamine) and __SLC6A4__ (serotonin) are candidates for depression in PD. We genotyped 24 tagging S
Sleep attacks are a common yet only recently recognized phenomenon in patients with Parkinson's disease (PD). Initially reported to occur only with particular dopamine agonists, sleep attacks have been observed with all dopaminergic drugs. [1][2][3] In the majority of affected patients, sleep attack